BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20357094)

  • 1. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.
    O'Connor C; Pertel T; Gray S; Robia SL; Bakowska JC; Luban J; Campbell EM
    J Virol; 2010 Jun; 84(12):5997-6006. PubMed ID: 20357094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
    Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
    J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
    Sastri J; Campbell EM
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of viral infectivity by tripartite motif proteins.
    Towers GJ
    Hum Gene Ther; 2005 Oct; 16(10):1125-32. PubMed ID: 16218773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α.
    Saha B; Chisholm D; Kell AM; Mandell MA
    PLoS Pathog; 2020 Oct; 16(10):e1009017. PubMed ID: 33052966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
    Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Solis GP; Ikeda Y
    J Biol Chem; 2010 Nov; 285(45):34508-17. PubMed ID: 20810659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
    Rold CJ; Aiken C
    PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A helical LC3-interacting region mediates the interaction between the retroviral restriction factor Trim5α and mammalian autophagy-related ATG8 proteins.
    Keown JR; Black MM; Ferron A; Yap M; Barnett MJ; Pearce FG; Stoye JP; Goldstone DC
    J Biol Chem; 2018 Nov; 293(47):18378-18386. PubMed ID: 30282803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM5α associates with proteasomal subunits in cells while in complex with HIV-1 virions.
    Lukic Z; Hausmann S; Sebastian S; Rucci J; Sastri J; Robia SL; Luban J; Campbell EM
    Retrovirology; 2011 Nov; 8():93. PubMed ID: 22078707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.
    Tareen SU; Emerman M
    Virology; 2011 Jan; 409(1):113-20. PubMed ID: 21035162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique features of TRIM5alpha among closely related human TRIM family members.
    Li X; Gold B; O'hUigin C; Diaz-Griffero F; Song B; Si Z; Li Y; Yuan W; Stremlau M; Mische C; Javanbakht H; Scally M; Winkler C; Dean M; Sodroski J
    Virology; 2007 Apr; 360(2):419-33. PubMed ID: 17156811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular and antiviral functions of TRIM5α].
    Khalfi S; Mérindol N; Berthoux L
    Virologie (Montrouge); 2020 Dec; 24(6):369-380. PubMed ID: 33441289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
    Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
    J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
    Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
    J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell biology of TRIM5α.
    Lukic Z; Campbell EM
    Curr HIV/AIDS Rep; 2012 Mar; 9(1):73-80. PubMed ID: 22193888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
    Keckesova Z; Ylinen LM; Towers GJ
    J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.